UnitedHealthcare
Xtandi (enzalutamide)
Drugs for Cancer : Drugs for Cancer
  • Prior Authorization: Documented Diagnosis: Yes
    Duration: 12 Month(s)
    Reauthorization Required: Yes

  • Quantity Limit: limit maximum 4 EA PER 1 day(s)
  • Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)

  • Orally administered anticancer medication.
  • Step Therapy: Metastatic Castrate-Sensitive Prostate Cancer (mCSPC), Non-Metastatic Prostate Cancer:
    ST Multiple Brands

    Metastatic Prostate Cancer:
    ST Single Brand